105 related articles for article (PubMed ID: 12799931)
1. [Therapy with opioids in liver or renal failure].
Tegeder I; Geisslinger G; Lötsch J
Schmerz; 1999 Jun; 13(3):183-95. PubMed ID: 12799931
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of opioids in liver disease.
Tegeder I; Lötsch J; Geisslinger G
Clin Pharmacokinet; 1999 Jul; 37(1):17-40. PubMed ID: 10451781
[TBL] [Abstract][Full Text] [Related]
3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
4. Opioid metabolites.
Lötsch J
J Pain Symptom Manage; 2005 May; 29(5 Suppl):S10-24. PubMed ID: 15907643
[TBL] [Abstract][Full Text] [Related]
5. Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
Bosilkovska M; Walder B; Besson M; Daali Y; Desmeules J
Drugs; 2012 Aug; 72(12):1645-69. PubMed ID: 22867045
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of opioids in renal dysfunction.
Davies G; Kingswood C; Street M
Clin Pharmacokinet; 1996 Dec; 31(6):410-22. PubMed ID: 8968655
[TBL] [Abstract][Full Text] [Related]
7. Effects of renal insufficiency on the pharmacokinetics and pharmacodynamics of opioid analgesics.
Chan GL; Matzke GR
Drug Intell Clin Pharm; 1987 Oct; 21(10):773-83. PubMed ID: 3322755
[TBL] [Abstract][Full Text] [Related]
8. Hepatic enzyme activity is the major factor determining elimination rate of high-clearance drugs in cirrhosis.
Callaghan R; Desmond PV; Paull P; Mashford ML
Hepatology; 1993 Jul; 18(1):54-60. PubMed ID: 8325621
[TBL] [Abstract][Full Text] [Related]
9. Opioids in renal failure and dialysis patients.
Dean M
J Pain Symptom Manage; 2004 Nov; 28(5):497-504. PubMed ID: 15504625
[TBL] [Abstract][Full Text] [Related]
10. Central nervous system toxicity associated with meperidine use in hepatic disease.
Danziger LH; Martin SJ; Blum RA
Pharmacotherapy; 1994; 14(2):235-8. PubMed ID: 8197046
[TBL] [Abstract][Full Text] [Related]
11. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
12. Normal metabolism of morphine in cirrhosis.
Patwardhan RV; Johnson RF; Hoyumpa A; Sheehan JJ; Desmond PV; Wilkinson GR; Branch RA; Schenker S
Gastroenterology; 1981 Dec; 81(6):1006-11. PubMed ID: 7286578
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic-pharmacodynamic modeling of opioids.
Lötsch J
J Pain Symptom Manage; 2005 May; 29(5 Suppl):S90-103. PubMed ID: 15907650
[TBL] [Abstract][Full Text] [Related]
14. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
15. Meperidine, remifentanil and tramadol but not sufentanil interact with alpha(2)-adrenoceptors in alpha(2A)-, alpha(2B)- and alpha(2C)-adrenoceptor knock out mice brain.
Höcker J; Weber B; Tonner PH; Scholz J; Brand PA; Ohnesorge H; Bein B
Eur J Pharmacol; 2008 Mar; 582(1-3):70-7. PubMed ID: 18234187
[TBL] [Abstract][Full Text] [Related]
16. The effect of acutely induced hepatic failure on remifentanil and fentanyl blood levels in a pig model.
Kostopanagiotou G; Markantonis SL; Arkadopoulos N; Andreadou I; Charalambidis G; Chondroudaki J; Costopanagiotou C; Smyrniotis V
Eur J Anaesthesiol; 2006 Jul; 23(7):598-604. PubMed ID: 16507181
[TBL] [Abstract][Full Text] [Related]
17. Morphine, opioids, and the feline pulmonary vascular bed.
Kaye AD; Hoover JM; Kaye AJ; Ibrahim IN; Fox C; Bajwa A; Anwar M; Fields AM; Baluch A; Huffman S; Chilian W
Acta Anaesthesiol Scand; 2008 Aug; 52(7):931-7. PubMed ID: 18477088
[TBL] [Abstract][Full Text] [Related]
18. [Indication and usage of opioids except morphine for chronic non-malignant intractable pain].
Saeki S
Masui; 2008 Nov; 57(11):1351-8. PubMed ID: 19039961
[TBL] [Abstract][Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
